EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study

Hasanthi Rathnadiwakara iD, Florence Cliquet iD, Marine Wasniewski iD, Jean-Christophe Thibault iD, Jean-Luc Schereffer iD, Mayuri Thammitiyagodage iD, Mohamed Ijas iD, Dulani Samaranayake iD, Mangala Gunatilake iD

Clinical and Experimental Vaccine Research · 2026 · 15 (2) · 151

DOI: 10.7774/cevr.2026.15.e13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Vaccine Research, 2026. Verfasst von Hasanthi Rathnadiwakara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and the 3Rs Centre for Laboratory Animal Science, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AntibodyDogsHumoral immunityNew Zealand white rabbitsRabies

Autor:innen und Institutionen

  • Department of Physiology and the 3Rs Centre for Laboratory Animal Science, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
  • EU/WOAH/WHO Reference Laboratory for Rabies, OMCL for Rabies Vaccines, ANSES-Nancy, Nancy, France.
  • JC&P Life Science Partners, Forcalquier, France.
  • Animal Centre, Medical Research Institute, Colombo, Sri Lanka.
  • Municipal Veterinary Department, Colombo Municipal Council, Colombo, Sri Lanka.
  • Department of Community Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

ORCID-Profile: Hasanthi Rathnadiwakara, Florence Cliquet, Marine Wasniewski, Jean-Christophe Thibault, Jean-Luc Schereffer, Mayuri Thammitiyagodage, Mohamed Ijas, Dulani Samaranayake, Mangala Gunatilake

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Rathnadiwakara, H., Cliquet, F., Wasniewski, M., Thibault, J. C., Schereffer, J. L., Thammitiyagodage, M., Ijas, M., Samaranayake, D., & Gunatilake, M. (2026). Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study. Clinical and Experimental Vaccine Research, 15(2), 151. https://doi.org/10.7774/cevr.2026.15.e13

Vancouver

Rathnadiwakara H, Cliquet F, Wasniewski M, Thibault JC, Schereffer JL, Thammitiyagodage M, et al. Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study. Clinical and Experimental Vaccine Research. 2026;15(2):151. doi:10.7774/cevr.2026.15.e13

BibTeX
@article{Rathnadiwakara2026,
  author = {Rathnadiwakara, Hasanthi and Cliquet, Florence and Wasniewski, Marine and Thibault, Jean-Christophe and Schereffer, Jean-Luc and Thammitiyagodage, Mayuri and Ijas, Mohamed and Samaranayake, Dulani and Gunatilake, Mangala},
  title = {Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study},
  journal = {Clinical and Experimental Vaccine Research},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {151},
  doi = {10.7774/cevr.2026.15.e13}
}
Kostenlos starten →